MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-20-0001458
Amylo Dex Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹60.75 Cr
▲ 7% YoY
Net profit · FY 2025
₹2.24 Cr
Net margin 3.7%
EBITDA · FY 2025
₹3.51 Cr
EBITDA margin 5.8%
Authorised capital
₹1.75 Cr
Registered with MCA
Paid-up capital
₹1.72 Cr
Issued & subscribed
Open charges
₹35 Lakh
Satisfied ₹24.4 Lakh
Company age
17 yrs
Est. 2009
Employees · EPFO
74
Provident fund records
About Amylo Dex Private Limited
Data last updated:
Amylo Dex Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the industrial enzymes and biochemicals segment of the chemicals and materials sector. It was incorporated on 14 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2009PTC066249. Its GSTIN is 36AARCS1407R1ZO (Telangana). The company holds 8 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹1.75 Cr and a paid-up capital of ₹1.72 Cr. It was formerly known as Star Dex Private Limited. It is led by directors Prabhavathi Busireddy and Vijaya Bhaskar Reddy Busireddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 302 S.V. Sumithra Apartments Sumithra Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹60.75 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.24 Cr (net margin 3.7%) and EBITDA of ₹3.51 Cr (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 12% over five years.
The company has about 74 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Amylodex. As per MCA filings, the company has open charges of ₹35 Lakh and satisfied charges of ₹24.4 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1.71 Cr; the latest was in December 2013. Its 6 peer companies in the Chemicals industry (Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Catalysts Bio-Technologies Private Limited with revenue of ₹164.58 Cr.
Amylo Dex Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0001458). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amylodex.com.
Company details
CIN U24100TG2009PTC066249
Registration Number 066249
Incorporation Date 14 December 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-20-0001458
CIN history
Amylo Dex has one previous CIN (Corporate Identification Number): U24100AP2009PTC066249. The current CIN is U24100TG2009PTC066249, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2009PTC066249 | Current |
| U24100AP2009PTC066249 | Previous |
Recognitions & Rankings of Amylo Dex
Contact details
Amylo Dex Private Limited's registered office is in Hyderabad, Telangana. Its website is amylodex.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address302 S.V. Sumithra Apartments Sumithra Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
To see the full contact details of Amylo Dex Private Limited, buy the company report.
Comprehensive company report
Amylo Dex Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Amylo Dex operates one associated brand: Amylodex. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of starch-based adhesives and modified starches in India. | amylodex.com |
Business activity
The main business activity of Amylo Dex is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Amylo Dex Private Limited, buy the company report.
Financials of Amylo Dex Private Limited
FY 2025 filings availableAmylo Dex Private Limited reported revenue of ₹60.75 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹60.75 Cr ▲ 7%
Net profit · FY 2025
₹2.24 Cr margin 3.7%
EBITDA · FY 2025
₹3.51 Cr margin 5.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 16%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 83%
3 years · compounded
▲ 4%
5 years · compounded
▲ 19%
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 7% growth in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.51 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.24 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 3.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amylo Dex Private Limited, buy the company report.
Board of directors of Amylo Dex Private Limited
Amylo Dex has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhavathi Busireddy | Director | 14 Dec 2009 | 16 Years 10 Months | Current |
| Vijaya Bhaskar Reddy Busireddy | Director | 14 Dec 2009 | 16 Years 10 Months | Current |
Peer comparison
Amylo Dex Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Catalysts Bio-Technologies Private Limited | ₹164.58 Cr (FY 2024) | 5.0% | Delhi, India | |||
| Anthem Cellutions ( India) Private Limited | ₹91.31 Cr (FY 2017) | -11.0% | Bangalore, Karnataka, India | |||
| Amylo Dex Private Limitedthis company | ₹60.75 Cr (FY 2025) | ₹2.24 Cr | 3.7% | 7.0% | 74 | Hyderabad, Telangana, India |
| Zytex Biotech Private Limited | ₹59.95 Cr (FY 2024) | 24.0% | Mumbai, Maharashtra, India | |||
| Lumis Biotech Private Limited | ₹57.84 Cr (FY 2024) | 6.0% | Mumbai, Maharashtra, India | |||
| Amster Microcell Private Limited | ₹55.81 Cr (FY 2025) | 50.0% | Kadi, Gujarat, India | |||
| Infinita Biotech Private Limited | ₹52.26 Cr (FY 2024) | 119.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Amylo Dex Private Limited, buy the company report.
Auditor
Amylo Dex Private Limited is audited by Hari and Gautham Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Hari and Gautham Associates | FY 2022 | 008379S |
Shareholding
The shareholding of Amylo Dex Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amylo Dex Private Limited, buy the company report.
Charges & borrowings
Open charges
₹35 Lakh
Satisfied charges
₹24.4 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Apr 2015 | 10611190 | Others | ₹35 Lakh | Open | |
| 22 Apr 2019 | 100269125 | Others | ₹24.4 Lakh | Satisfied |
To see the full charge records of Amylo Dex Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Amylo Dex Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1.71 Cr; the latest was in December 2013.
Total deals
1
Funding round
1
Disclosed funding
₹1.71 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2013 | Funding round | ₹1.71 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amylo Dex Private Limited has 1 court case on record: 1 filed by Amylo Dex. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Insolvency matter | Filed by the company against Atharva Corrugations Pvt Ltd | Disposed |
To see the full case history of Amylo Dex Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Amylo Dex Private Limited was last rated by Crisil on 09 Dec 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 09 Dec 2021 |
To see the full credit ratings and regulatory alerts of Amylo Dex Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amylo Dex Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Amylo Dex Private Limited has a workforce of 74 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
74
Active EPFO establishments
1
Employee growth
5.71%
GST
Amylo Dex has 8 GST registrations: 5 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
8
Active
5
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AARCS1407R1ZO | Telangana | Active | 01 Jul 2017 |
| 19AARCS1407R1ZK | West Bengal | Active | 01 Jul 2017 |
| 33AARCS1407R1ZU | Tamil Nadu | Active | 01 Jul 2017 |
| 27AARCS1407R1ZN | Maharashtra | Active | 04 May 2018 |
To see the full GST registrations and return filing status of Amylo Dex Private Limited, buy the company report.
Recent activity
Amylo Dex Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Prabhavathi Busireddy was appointed as Director on 14 Dec 2009.
AGM
Amylo Dex Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Amylo Dex Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others of Rs. 0.35 Cr registered on 28 Apr 2015 with Charge ID 10611190 was modified on 08 Sep 2023.
Charges
A charge registered on 22 Apr 2019 via Charge ID 100269125 with Others was fully satisfied on 16 May 2022.
Charges
A charge with Others amounted to Rs. 0.24 Cr with Charge ID 100269125 was registered on 22 Apr 2019.
Charges
A charge with Others amounted to Rs. 0.35 Cr with Charge ID 10611190 was registered on 28 Apr 2015.
Appointed
Prabhavathi Busireddy was appointed as Director.
Appointed
Vijaya Bhaskar Reddy Busireddy was appointed as Director.
Incorporation
14 Dec 2009
Amylo Dex Private Limited was registered on 14 Dec 2009 with Roc Hyderabad & aged 16 years 10 months as per MCA records.
Frequently asked questions
Amylo Dex is an active private limited company based in Hyderabad, Telangana, India. The company works in industrial enzymes and biochemicals, within the chemicals and materials industry. It was incorporated on 14 December 2009 (17+ years old) and is registered under CIN U24100TG2009PTC066249.
Amylo Dex has 2 current directors:
- Prabhavathi Busireddy - Director
- Vijaya Bhaskar Reddy Busireddy - Director
The latest financial statements of Amylo Dex on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Amylo Dex is 36AARCS1407R1ZO, registered in Telangana. The company has 8 GST registrations in all, of which 5 are active and 3 are cancelled or inactive. Other active GSTINs include 19AARCS1407R1ZK (West Bengal), 33AARCS1407R1ZU (Tamil Nadu), 27AARCS1407R1ZN (Maharashtra).
The CIN (Corporate Identification Number) of Amylo Dex is U24100TG2009PTC066249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amylo Dex has 1 court case on record: 1 filed by the company.
Amylo Dex was incorporated on 14 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
Amylo Dex has 1 deal on record (1 funding round), with disclosed funding of ₹1.71 Cr; the latest was in December 2013.
The peers of Amylo Dex by revenue are Catalysts Bio-Technologies Private Limited, Anthem Cellutions ( India) Private Limited, Zytex Biotech Private Limited, Lumis Biotech Private Limited, Amster Microcell Private Limited and 1 more, all in the Chemicals industry (Enzymes), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Prabhavathi Busireddy was appointed as Director on 14 Dec 2009. Vijaya Bhaskar Reddy Busireddy was appointed as Director on 14 Dec 2009.
Yes, Amylo Dex is registered as a small enterprise under Udyam registration (number: UDYAM-TS-20-0001458).